Chungmo Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Chungmo Yang has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Jung Ryeol Lee
Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea
4 shared publications - Kangwon Lee
Seoul National University
4 shared publications - Nanum Chung
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea
4 shared publications - Hyuk Sang Yoo
Kangwon National University
3 shared publications - Chae Young Song
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea
2 shared publications - Jungwoo Shin
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea
2 shared publications
Latest Publications
- 4 June 2026
- Published by IOP Publishing in Biofabrication
- Vol. 18 (3)
Matrix-tuned hyaluronic nanofibrils promoting regenerative ocular surfacing with minimal scarring
Corneal epithelial damage remains a considerable clinical challenge, often leading to delayed wound healing and impaired vision. Hyaluronic acid (HA)-based nanofibers face fabrication and stability challenges, reducing their translational potential for corneal regeneration. The fabrication and characterization of aminolyzed polycaprolactone (PCL) nanofibrils (aNFs) with manipulated HA conjugation was investigated to enhance human corneal epithelial cell (hCEC) cell adhesion and proliferation. HA was chemically immobilized on aNF via aza-Michael addition using varying FeCl 3 concentrations over 24 h. Quantitative, turbidimetric, and colorimetric analyses confirmed HA conjugation to aNFs after 24h of reaction.Additionally, HA-conjugated NFs exhibited increased swelling and attenuated protein adsorption compared to aNFs. HA-conjugated nanofibrils (HA@NF) exhibited no detectable cytotoxicity toward hCECs. hCECs adhesion gradually increased proportionally with the degree of HA conjugation on HA@NFs. HA@NF24 induced the highest gene expression of hCEC-specific and proliferation markers, suggesting improved identity maintenance and hCEC proliferation in 3D cell sheet cultivation. Corneal wound healing studies with wild-type rabbits, HA@NFs accelerated recovery, highlighting their therapeutic potential. These results demonstrate that HA-optimized PCL nanofibrils are promising therapeutic materials for corneal regeneration and ocular tissue repair.
- 4 June 2026
- Published by IOP Publishing in Biofabrication
- Vol. 18 (3)
Matrix-tuned hyaluronic nanofibrils promoting regenerative ocular surfacing with minimal scarring
Corneal epithelial damage remains a considerable clinical challenge, often leading to delayed wound healing and impaired vision. Hyaluronic acid (HA)-based nanofibers face fabrication and stability challenges, reducing their translational potential for corneal regeneration. The fabrication and characterization of aminolyzed polycaprolactone (PCL) nanofibrils (aNFs) with manipulated HA conjugation was investigated to enhance human corneal epithelial cell (hCEC) cell adhesion and proliferation. HA was chemically immobilized on aNF via aza-Michael addition using varying FeCl 3 concentrations over 24 h. Quantitative, turbidimetric, and colorimetric analyses confirmed HA conjugation to aNFs after 24h of reaction.Additionally, HA-conjugated NFs exhibited increased swelling and attenuated protein adsorption compared to aNFs. HA-conjugated nanofibrils (HA@NF) exhibited no detectable cytotoxicity toward hCECs. hCECs adhesion gradually increased proportionally with the degree of HA conjugation on HA@NFs. HA@NF24 induced the highest gene expression of hCEC-specific and proliferation markers, suggesting improved identity maintenance and hCEC proliferation in 3D cell sheet cultivation. Corneal wound healing studies with wild-type rabbits, HA@NFs accelerated recovery, highlighting their therapeutic potential. These results demonstrate that HA-optimized PCL nanofibrils are promising therapeutic materials for corneal regeneration and ocular tissue repair.
- Open Access
- 17 March 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (17) , 15410-15419
Anisotropic gold nanochains with dual-ligand interfaces for theranostic immune activation
Gold nanorods functionalized with azide assemble end-to-end into nanochains. The Fc-modified chains engage NK cells via receptor recognition, significantly enhancing antibody-dependent cellular cytotoxicity (ADCC) in a chain length-dependent manner.
- 17 March 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (17) , 15410-15419
Open AccessAnisotropic gold nanochains with dual-ligand interfaces for theranostic immune activation
Gold nanorods functionalized with azide assemble end-to-end into nanochains. The Fc-modified chains engage NK cells via receptor recognition, significantly enhancing antibody-dependent cellular cytotoxicity (ADCC) in a chain length-dependent manner.
- Open Access
- 22 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30
Biomaterials for Reproductive Restoration: Translating Engineering Innovations
Advances in cancer therapy, delayed parenthood, and an increasing number of reproductive disorders have intensified the need for the effective preservation of fertility. However, current clinical strategies such as ovarian tissue cryopreservation, transplantation, and hormonal stimulation remain limited in scope and efficacy. Biomaterials have emerged as powerful tools to overcome these limitations, enabling fertility preservation and functional restoration of reproductive and endocrine systems. Recent progress has included the development of hydrogel-based systems for in vitro follicle maturation, bioengineered scaffolds for ovarian tissue support, and artificial ovaries capable of hormone secretion and oocyte development. These platforms are increasingly incorporating immunomodulatory features to address rejection and enhance graft integration. Beyond preservation, biomaterials are also being harnessed to repair reproductive damage caused by conditions such as primary ovarian insufficiency, intrauterine adhesions, and endometriosis. Through tunable biochemical and mechanical properties, materials can direct tissue regeneration, modulate inflammation, and restore physiological functions. Emerging technologies, including biofabrication with reproductive-specific bioinks, organoid models, hormone-responsive systems, and artificial intelligence-driven biomaterial designs, are accelerating innovation toward translational applications. Collectively, these developments represent a paradigm shift in reproductive medicine from passive preservation to active regenerative strategies. This review highlights the state-of-the-art biomaterial-enabled fertility restoration and outlines future directions toward personalized, functional, and clinically viable solutions.
- 22 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30
Open AccessBiomaterials for Reproductive Restoration: Translating Engineering Innovations
Advances in cancer therapy, delayed parenthood, and an increasing number of reproductive disorders have intensified the need for the effective preservation of fertility. However, current clinical strategies such as ovarian tissue cryopreservation, transplantation, and hormonal stimulation remain limited in scope and efficacy. Biomaterials have emerged as powerful tools to overcome these limitations, enabling fertility preservation and functional restoration of reproductive and endocrine systems. Recent progress has included the development of hydrogel-based systems for in vitro follicle maturation, bioengineered scaffolds for ovarian tissue support, and artificial ovaries capable of hormone secretion and oocyte development. These platforms are increasingly incorporating immunomodulatory features to address rejection and enhance graft integration. Beyond preservation, biomaterials are also being harnessed to repair reproductive damage caused by conditions such as primary ovarian insufficiency, intrauterine adhesions, and endometriosis. Through tunable biochemical and mechanical properties, materials can direct tissue regeneration, modulate inflammation, and restore physiological functions. Emerging technologies, including biofabrication with reproductive-specific bioinks, organoid models, hormone-responsive systems, and artificial intelligence-driven biomaterial designs, are accelerating innovation toward translational applications. Collectively, these developments represent a paradigm shift in reproductive medicine from passive preservation to active regenerative strategies. This review highlights the state-of-the-art biomaterial-enabled fertility restoration and outlines future directions toward personalized, functional, and clinically viable solutions.
- 1 October 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (22) , 6446-6457
A proof-of-concept study on an injectable artificial ovary using a xenogeneic ECM for fertility restoration
The development of artificial ovaries presents a promising strategy for patients facing infertility due to chemotherapy or high metastatic potential cancers, where conventional ovarian tissue transplantation poses significant risks. Our study introduces an “injectable artificial ovary” leveraging a xenogeneic extracellular matrix (ECM) hydrogel derived from bovine ovarian tissue. The ECM hydrogel obtained from bovine ovaries and prepared through decellularization, milling, and digestion is injectable and thermo-responsive, preserving the matrix structure without cytotoxicity. This innovative approach delivers a non-surgical alternative for fertility preservation by harnessing the bioactive and adaptable properties of ECM hydrogels to support ovarian follicle maturation and restore endocrine functions. In our results, the hydrogel demonstrated temperature-responsive gelation and biocompatibility, promoting follicle development and increasing 17β-estradiol secretion. Such advancements highlight the potential of this technique to redefine fertility treatments and regenerative medicine. Notably, the in situ development of ovarian follicles within the injected hydrogel led to successful ovulation after subcutaneous implantation. Although our study did not demonstrate oocyte maturation and fertilization, our findings suggest that this approach could serve as a heterotopic artificial ovary, offering a promising solution for fertility preservation in patients with high metastasis risk cancers who cannot undergo conventional treatments. This strategy advances artificial ovary technologies, presenting new possibilities for reproductive health and fertility preservation interventions.
- 1 October 2025
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 13 (22) , 6446-6457
A proof-of-concept study on an injectable artificial ovary using a xenogeneic ECM for fertility restoration
The development of artificial ovaries presents a promising strategy for patients facing infertility due to chemotherapy or high metastatic potential cancers, where conventional ovarian tissue transplantation poses significant risks. Our study introduces an “injectable artificial ovary” leveraging a xenogeneic extracellular matrix (ECM) hydrogel derived from bovine ovarian tissue. The ECM hydrogel obtained from bovine ovaries and prepared through decellularization, milling, and digestion is injectable and thermo-responsive, preserving the matrix structure without cytotoxicity. This innovative approach delivers a non-surgical alternative for fertility preservation by harnessing the bioactive and adaptable properties of ECM hydrogels to support ovarian follicle maturation and restore endocrine functions. In our results, the hydrogel demonstrated temperature-responsive gelation and biocompatibility, promoting follicle development and increasing 17β-estradiol secretion. Such advancements highlight the potential of this technique to redefine fertility treatments and regenerative medicine. Notably, the in situ development of ovarian follicles within the injected hydrogel led to successful ovulation after subcutaneous implantation. Although our study did not demonstrate oocyte maturation and fertilization, our findings suggest that this approach could serve as a heterotopic artificial ovary, offering a promising solution for fertility preservation in patients with high metastasis risk cancers who cannot undergo conventional treatments. This strategy advances artificial ovary technologies, presenting new possibilities for reproductive health and fertility preservation interventions.
- 16 July 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (36) , e2311684
Plant‐Based Shape Memory Cryogel for Hemorrhage Control
The escalating global demand for sustainable manufacturing, motivated by concerns over energy conservation and carbon footprints, encounters challenges due to insufficient renewable materials and arduous fabrication procedures to fulfill specific requirements in medical and healthcare systems. Here, biosafe pollen cryogel is engineered as effective hemostats without additional harmful crosslinkers to treat deep noncompressible wounds. A straightforward and low‐energy approach is involved in forming stable macroporous cryogel, benefiting from the unique micro‐hierarchical structures and chemical components of non‐allergenic plant pollen. It is demonstrated that the pollen cryogel exhibits rapid water/blood‐triggered shape‐memory properties within 2 s. Owing to their inherent nano/micro hierarchical structure and abundant chemical functional groups on the pollen surface, the pollen cryogel shows effective hemostatic performance in a mouse liver penetration model, which is easily removed after usage. Overall, the self‐crosslinking pollen cryogel in this work pioneers a framework of potential clinical applications for the first‐hand treatment on deep noncompressible wounds.
- 16 July 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (36) , e2311684
Plant‐Based Shape Memory Cryogel for Hemorrhage Control
The escalating global demand for sustainable manufacturing, motivated by concerns over energy conservation and carbon footprints, encounters challenges due to insufficient renewable materials and arduous fabrication procedures to fulfill specific requirements in medical and healthcare systems. Here, biosafe pollen cryogel is engineered as effective hemostats without additional harmful crosslinkers to treat deep noncompressible wounds. A straightforward and low‐energy approach is involved in forming stable macroporous cryogel, benefiting from the unique micro‐hierarchical structures and chemical components of non‐allergenic plant pollen. It is demonstrated that the pollen cryogel exhibits rapid water/blood‐triggered shape‐memory properties within 2 s. Owing to their inherent nano/micro hierarchical structure and abundant chemical functional groups on the pollen surface, the pollen cryogel shows effective hemostatic performance in a mouse liver penetration model, which is easily removed after usage. Overall, the self‐crosslinking pollen cryogel in this work pioneers a framework of potential clinical applications for the first‐hand treatment on deep noncompressible wounds.
- Open Access
- 1 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 28, 0054
Injectable Biomimetic Hydrogel Constructs for Cell-Based Menopausal Hormone Therapy with Reduced Breast Cancer Potential
Hormone replacement therapy (HRT) has been a primary method in menopausal women and patients with ablated ovaries, but safety has been a concern. Cell-based HRT has emerged as an alternative approach without side effects causing pharmaceutical HRT via 3-dimensionally engineered constructs layering ovarian hormone-producing cells. In this study, we applied micro-sized ovarian cell-laden hydrogel beads as an approach to cell-based HRT using a minimally invasive method in the menopausal rat model. Here, we constructed GC/TC-laden microbeads (GTBs; GC, granulosa cell; TC, theca cell) that allow crosstalk between endocrine cells, encapsulating multiple beads for the figuration of the original ovary. We assessed the ovarian hormone production function of GTB through in vitro culture for 90 days. We applied it to a menopausal rat model and confirmed that GTB-injected rats restored their endocrine function, leading to the regeneration of the thinned endometrium and the maintenance of regular estrous cycles in some individuals. Additionally, it was observed to alleviate menopausal symptoms, including body weight gain and osteoporosis. Notably, the GTB-injected rats did not show mammary gland hyperplasia observed in the pharmaceutical HRT groups and exhibited fewer p53- and KI67-positive and an increase in phosphatase and tensin homolog-positive mammary gland epithelial cells compared to pharmaceutical hormone-treated rats. These results suggest that GTB-based HRT could present a lower risk of breast cancer compared to conventional pharmaceutical-HRT use. Our study highlights the potential of cell-based HRT using an injectable artificial ovary, offering a safer alternative for women requiring HRT.
- 1 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 28, 0054
Open AccessInjectable Biomimetic Hydrogel Constructs for Cell-Based Menopausal Hormone Therapy with Reduced Breast Cancer Potential
Hormone replacement therapy (HRT) has been a primary method in menopausal women and patients with ablated ovaries, but safety has been a concern. Cell-based HRT has emerged as an alternative approach without side effects causing pharmaceutical HRT via 3-dimensionally engineered constructs layering ovarian hormone-producing cells. In this study, we applied micro-sized ovarian cell-laden hydrogel beads as an approach to cell-based HRT using a minimally invasive method in the menopausal rat model. Here, we constructed GC/TC-laden microbeads (GTBs; GC, granulosa cell; TC, theca cell) that allow crosstalk between endocrine cells, encapsulating multiple beads for the figuration of the original ovary. We assessed the ovarian hormone production function of GTB through in vitro culture for 90 days. We applied it to a menopausal rat model and confirmed that GTB-injected rats restored their endocrine function, leading to the regeneration of the thinned endometrium and the maintenance of regular estrous cycles in some individuals. Additionally, it was observed to alleviate menopausal symptoms, including body weight gain and osteoporosis. Notably, the GTB-injected rats did not show mammary gland hyperplasia observed in the pharmaceutical HRT groups and exhibited fewer p53- and KI67-positive and an increase in phosphatase and tensin homolog-positive mammary gland epithelial cells compared to pharmaceutical hormone-treated rats. These results suggest that GTB-based HRT could present a lower risk of breast cancer compared to conventional pharmaceutical-HRT use. Our study highlights the potential of cell-based HRT using an injectable artificial ovary, offering a safer alternative for women requiring HRT.
- Open Access
- 1 January 2022
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 63 (7) , 648-656
Ovarian Tissue-Based Hormone Replacement Therapy Recovers Menopause-Related Signs in Mice
Yoo D, et al. Yonsei Med J. 2022 Jul;63(7):648-656. https://doi.org/10.3349/ymj.2022.63.7.648
- 1 January 2022
- Published by Yonsei University College of Medicine in Yonsei Medical Journal
- Vol. 63 (7) , 648-656
Open AccessOvarian Tissue-Based Hormone Replacement Therapy Recovers Menopause-Related Signs in Mice
Yoo D, et al. Yonsei Med J. 2022 Jul;63(7):648-656. https://doi.org/10.3349/ymj.2022.63.7.648
- 7 February 2008
- Published by SPIE-Intl Soc Optical Eng
- Vol. 6887, 688702-688702-11
A novel diffractive micro-optical modulator for mobile display applications
A diffractive optical modulator has been fabricated based on a micromachining process. Novel properties of its fast response time and dynamics were fully understood and demonstrated for the strong potentials in embedded mobile laser display. Bridged thin film piezo-actuators with so called open mirror diffraction structure has been designed. Optical level package also was achieved to successfully prove its display application qualities. Display circuits and driving logic were developed to finally confirm the single-panel laser display at a 240Hz VGA (640×480). With its efficiency of more than 75% and 13cc volume optical engine with the MEMS-based VGA resolution SOM showed 7 lm brightness at a 1.5W electrical power consumption. Detailed design principle, fabrication, packaging and performances of the invented SOM are described.
- 7 February 2008
- Published by SPIE-Intl Soc Optical Eng
- Vol. 6887, 688702-688702-11
A novel diffractive micro-optical modulator for mobile display applications
A diffractive optical modulator has been fabricated based on a micromachining process. Novel properties of its fast response time and dynamics were fully understood and demonstrated for the strong potentials in embedded mobile laser display. Bridged thin film piezo-actuators with so called open mirror diffraction structure has been designed. Optical level package also was achieved to successfully prove its display application qualities. Display circuits and driving logic were developed to finally confirm the single-panel laser display at a 240Hz VGA (640×480). With its efficiency of more than 75% and 13cc volume optical engine with the MEMS-based VGA resolution SOM showed 7 lm brightness at a 1.5W electrical power consumption. Detailed design principle, fabrication, packaging and performances of the invented SOM are described.